Omeprazole/amoxicillin/rifabutin, sold under the brand name Talicia, is a fixed-dose combination medication used for the treatment of Helicobacter pylori infection. It is taken by mouth. It was approved for medical use in the United States in November 2019.
References
External links "Omeprazole". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 23 November 2016. "Amoxicillin". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 1 December 2016. "Rifabutin". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on 27 August 2018. Clinical trial number NCT03198507 for "ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator (ERADICATE Hp2)" at ClinicalTrials.gov Clinical trial number NCT01980095 for "ERADICATE Hp - Treating Helicobacter Pylori With RHB-105 (ERADICATE Hp)" at ClinicalTrials.gov
